BTG3 and colitis: Sakakida et al.19observed a higher frequency of positive ANA in patients who developed colitis, although ANA was not associated with irAEs of any grade, corroborating results by Mouri et al.25Conversely, Morimoto et al.21reported a higher discontinuation rate of treatment due to severe adverse events in the ANA positive group.